Skip to content

Veeva Systems VEEV Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
-$17.8M-168%
Revvity logo
RevvityRVTY
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$882.9M+16.3%
Gross profit$662.0M+13.1%
Operating income$273.1M+16.8%
Net income$260.9M+14.4%
EPS (diluted)$1.57+14.6%

Balance sheet

See full
Cash & equivalents$1.9B-3.5%
Total debt$103.1M+33.5%
Total equity$7.3B+17.6%
Total assets$9.1B+17.6%

Cash flow

See full
Operating cash flow$1.1B+28.5%
CapEx$2.3M
Free cash flow$110.6M

Valuation

See full
Market cap$24.9B-31.2%
Enterprise value$23.11B-32.6%
P/E26.5×-19.9×
P/S7.5×-5.2×

Profitability

See full
Gross margin75%-0.5pp
Operating margin28.8%+1.8pp
Net margin28.4%+1.0pp
FCF margin37.2%

Returns & leverage

See full
Return on equity13.9%-0.1pp
Debt / equity0.0×
Current ratio4.7×+0.1×

Where this comes from

Reported directly by Veeva Systems in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Veeva Systems’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veeva Systems's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veeva Systems's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
Veeva Systems (VEEV) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of $475.35M in Q1 2026.
How has Veeva Systems's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation changed year-over-year?
Veeva Systems's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation decreased by 43.8% year-over-year, from $846.2M to $475.35M.
What is the long-term trend for Veeva Systems's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
Over 2 years (2022 to 2024), Veeva Systems's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation has grown at a -34.1% compound annual growth rate (CAGR), from $421.42M to -$182.98M.